How One CEO Is Changing Life Sciences Innovation

Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on…    Read more

CEO of Paragon Biosciences On Why Innovation In Pharma Is Hard

Jeff Aronin, who is the founder, chairman and CEO of Paragon Biosciences, spoke with Chief Executive about why healthcare is stagnant from an innovation standpoint, the importance in doing meaningful work and more. Read about Jeff Aronin’s…    Read more

Jeff Aronin Wins the 2019 BIG Innovation Award for Leadership

CHICAGO–(BUSINESS WIRE)–Paragon Biosciences Chairman and CEO Jeffrey S. Aronin won a 2019 BIG Innovation Award presented by the Business Intelligence Group. The award honors executives whose leadership improves quality of life. Read the full article…    Read more

Chicago Gala: Shaping a Brighter Tomorrow

The Midwest Region hosted a memorable Gala Dinner under the theme of “Breakthrough: Celebrating Discoveries. Shaping Tomorrow.” More than 500 community and industry leaders came together at the Fairmont Chicago Millennium Park to honor Jeffrey…    Read more